STAAR Surgical Net Income 2010-2023 | STAA
STAAR Surgical net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
STAAR Surgical Annual Net Income
(Millions of US $) |
| 2023 |
$21 |
| 2022 |
$40 |
| 2021 |
$28 |
| 2020 |
$6 |
| 2019 |
$14 |
| 2018 |
$5 |
| 2017 |
$-2 |
| 2016 |
$-12 |
| 2015 |
$-7 |
| 2014 |
$-8 |
| 2013 |
$0 |
| 2012 |
$-2 |
| 2011 |
$1 |
| 2010 |
$0 |
| 2009 |
$-6 |
STAAR Surgical Quarterly Net Income
(Millions of US $) |
| 2023-12-31 |
$8 |
| 2023-09-30 |
$5 |
| 2023-06-30 |
$6 |
| 2023-03-31 |
$3 |
| 2022-12-31 |
$7 |
| 2022-09-30 |
$10 |
| 2022-06-30 |
$13 |
| 2022-03-31 |
$10 |
| 2021-12-31 |
$8 |
| 2021-09-30 |
$6 |
| 2021-06-30 |
$9 |
| 2021-03-31 |
$5 |
| 2020-12-31 |
$3 |
| 2020-09-30 |
$4 |
| 2020-06-30 |
$-1 |
| 2020-03-31 |
$-0 |
| 2019-12-31 |
$6 |
| 2019-09-30 |
$2 |
| 2019-06-30 |
$4 |
| 2019-03-31 |
$1 |
| 2018-12-31 |
$1 |
| 2018-09-30 |
$1 |
| 2018-06-30 |
$2 |
| 2018-03-31 |
$1 |
| 2017-12-31 |
$-0 |
| 2017-09-30 |
$1 |
| 2017-06-30 |
$-1 |
| 2017-03-31 |
$-2 |
| 2016-12-31 |
$-0 |
| 2016-09-30 |
$-2 |
| 2016-06-30 |
$-2 |
| 2016-03-31 |
$-8 |
| 2015-12-31 |
$-1 |
| 2015-09-30 |
$-2 |
| 2015-06-30 |
$-2 |
| 2015-03-31 |
$-2 |
| 2014-12-31 |
$-3 |
| 2014-09-30 |
$-3 |
| 2014-06-30 |
$-2 |
| 2014-03-31 |
$-1 |
| 2013-12-31 |
$-1 |
| 2013-09-30 |
$1 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
$-1 |
| 2012-09-30 |
$-0 |
| 2012-06-30 |
$-0 |
| 2012-03-31 |
$0 |
| 2011-12-31 |
$0 |
| 2011-09-30 |
$0 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$0 |
| 2010-12-31 |
$-1 |
| 2010-09-30 |
$-1 |
| 2010-06-30 |
$-2 |
| 2010-03-31 |
$4 |
| 2009-12-31 |
$-1 |
| 2009-09-30 |
$-2 |
| 2009-06-30 |
$-1 |
| 2009-03-31 |
$-2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.141B |
$0.322B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
